Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Apostatin-1 (Apt-1) is a novel TRADD inhibitor. Apostatin-1 can bind to a pocket on the N-terminal TRAF2 binding domain of TRADD.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 31.00 | |
2 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 72.00 | |
10 mg | In stock | $ 122.00 | |
25 mg | In stock | $ 247.00 | |
50 mg | In stock | $ 397.00 | |
100 mg | In stock | $ 589.00 | |
500 mg | In stock | $ 1,280.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 79.00 |
Description | Apostatin-1 (Apt-1) is a novel TRADD inhibitor. Apostatin-1 can bind to a pocket on the N-terminal TRAF2 binding domain of TRADD. |
In vitro | Apostatin-1 inhibited bortezomib induced apoptosis and ripk1 dependent apoptosis (RDA) with the IC50 of ~1μM. |
Synonyms | Apt-1 |
Molecular Weight | 345.5 |
Formula | C19H27N3OS |
CAS No. | 2559703-06-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 9 mg/mL(26.06 mM), Sonication is recommended.
DMSO: 65 mg/mL(188.13 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Apostatin-1 2559703-06-7 Others Apostatin 1 TRADD Beclin1 RIPK Autophagy SH-SY5Y Receptor-interacting protein kinases Apoptosis Apostatin1 HT-29 Jurkat cells RIP kinase inhibit beclin 1 Apt-1 Inhibitor Atg6 Apt1 Apt 1 Necroptosis inflammatory responses HeLa RIPK1 inhibitor